ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
196 hedge funds and large institutions have $2.13B invested in Intercept Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 101 increasing their positions, 39 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
196
Holders Change
-6
Holders Change %
-2.97%
% of All Funds
4.26%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
31
Increased
101
Reduced
39
Closed
33
Calls
$103M
Puts
$92M
Net Calls
+$11.2M
Net Calls Change
+$234M
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$55.3M |
| 2 |
JPMorgan Chase & Co
New York
|
+$42.6M |
| 3 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$34.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.4M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$30.9M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$72.5M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$22.9M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$13.7M |
| 4 |
Goldman Sachs
New York
|
-$12.4M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.1M |
